FDA inspection

Bristol Myers Squibb: FDA inspection ending May 24, 2021

FDA inspection 1144339 · No Action Indicated (NAI) · Lawrenceville, NJ

Key facts

Inspection ID 1144339
Firm Bristol Myers Squibb
FEI number 1000527006
Address Route 206 & Province Line Road
City Lawrenceville
State NJ
ZIP 08648
Country United States
Fiscal year 2021
Inspection end date May 24, 2021
Classification No Action Indicated (NAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections